Monday - November 17, 2025
UCLA Health Jonsson Comprehensive Cancer Center: Therapy Delays Progression of Recurrent Prostate Cancer
November 13, 2025
LOS ANGELES, California, Nov. 13 (TNSjou) -- The UCLA Health Jonsson Comprehensive Cancer Center issued the following news release:

* * *

Therapy delays progression of recurrent prostate cancer

Adding PSMA-targeting radioligand therapy to stereotactic body radiotherapy more than doubled progression-free survival in men with recurrent prostate cancer

*

Patients with recurring prostate cancer who were treated with a new PSMA-targeted . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products